MNKD 2018 Proxy Statement

(3) Includes 2,743 shares which Mr. Castagna has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options. (4) Includes 17,210 shares which Mr. Pfeffer has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options. On May 25, 2017, Mr. Pfeffer ceased to be the Chief Executive Officer and Chief Financial Officer upon the appointment of Michael Castagna as the Chief Executive Officer and member of the Board of Directors. In August 2017, Mr. Pfeffer resigned from the Board of Directors. (5) Includes 2,911 shares which Ms. Alinaya has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options. On May 25, 2017, Ms. Alinaya was Acting Chief Financial Officer until the appointment of Steven B. Binder as Chief Financial Officer on July 17, 2017. (6) Includes 3,333 shares which Mr. Tross has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options. (7) Includes 4,621 shares which Mr. Thomson has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options. (8) Includes 4,315 shares which Mr. Kocinsky has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options. (9) Includes 1,989 options and 348 restricted stock units which Mr. Consiglio has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options and vesting of restricted stock units. (10) Includes 2,364 options and 348 restricted stock units which Dr. Friedman has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options and vesting of restricted stock units. (11) Includes 1,929 options and 348 restricted stock units which Mr. Kresa has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options and vesting of restricted stock units. (12) Includes 2,128 options and 348 restricted stock units which Mr. MacCallum has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options and vesting of restricted stock units. (13) Includes 2,128 options and 348 restricted stock units which Mr. Nordhoff has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options and vesting of restricted stock units. (14) Includes 2,256 options and 348 restricted stock units which Dr. Shannon has the right to acquire within 60 days of March 19, 2018 pursuant to the exercise of outstanding options and vesting of restricted stock units. (15) Includes the shares described in notes (3) and (5) through (14) above, and 2,000 shares owned by another executive officer. 41